General Information of the Compound
| Compound ID |
CP0385010
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[2-(furan-2-yl)-5-(propan-2-ylamino)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-yl]-2-phenylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H19N7O2
|
||||||||||||||||||
| Molecular Weight |
377.408
|
||||||||||||||||||
| Canonical SMILES |
CC(C)Nc1nc(NC(=O)Cc2ccccc2)n2nc(nc2n1)-c1ccco1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H19N7O2/c1-12(2)20-17-23-18(21-15(27)11-13-7-4-3-5-8-13)26-19(24-17)22-16(25-26)14-9-6-10-28-14/h3-10,12H,11H2,1-2H3,(H2,20,21,22,23,24,25,27)
Show/Hide
|
||||||||||||||||||
| InChIKey |
DDBNUUGAISIDIP-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01278, Adenosine receptor A2b
Protein ID: PT01279, Adenosine receptor A3